Richard Dana Ono insider trades
Open-market stock purchases and sales by Richard Dana Ono, Director at Lipocine Inc, from SEC Form 4 filings since Jan 6, 2014.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -72%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | LPCN Lipocine Inc | Bought (not open market) | $3.9K |